Poseida Therapeutics: A Look into Third Quarter 2024 Updates and Financial Results
Strong Collaboration Momentum and Positive Financial Results for Poseida Therapeutics Expansion of CAR-T Partnership and Introduction of Second Solid Tumor Research Program Target Poseida Therapeutics, a clinical-stage allogeneic cell therapy and genetic medicines company, has reported strong collaboration momentum with the expansion of their partnership with Roche and the nomination of a second solid tumor…